Taysha Gene Therapies, Inc. Common Stock TSHA
$4.11
+4.31%
at last close
Analyst Consensus
- Consensus Rating
- Buy (11 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $12.80
- Implied Upside
- +211.4%
- Price Target Range
- $10.00 – $17.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-17 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Outperform | — |
| 2026-07-21 | Goldman SachsSalveen Richter |
Maintains | Buy | $11 → $13 |
| 2026-07-02 | CitizensSilvan Turkcan |
Reiterates | Market outperform | $11 |
| 2026-06-30 | NeedhamGil Blum |
Maintains | Buy | $12 |
| 2026-06-30 | BairdJack Allen |
Maintains | Outperform | $12 → $15 |
| 2026-06-23 | BMO CapitalKeith Tapper |
Maintains | Outperform | $10 → $14 |
| 2026-06-23 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $9 → $10 |
| 2026-06-23 | CitizensSilvan Tuerkcan |
Maintains | Market outperform | $8 → $11 |
| 2026-06-22 | NeedhamGil Blum |
Maintains | Buy | $12 |
| 2026-04-06 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $14 → $17 |
| 2026-03-19 | NeedhamGil Blum |
Maintains | Buy | $10 → $12 |
| 2026-03-19 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $12 |
| 2026-03-03 | NeedhamGil Blum |
Reiterates | Buy | $10 |
| 2026-01-06 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $12 |
| 2026-01-05 | Wells FargoYanan Zhu |
Maintains | Overweight | $8 → $11 |
| 2025-11-05 | CitizensSilvan Tuerkcan |
Maintains | Market outperform | $6 → $8 |
| 2025-11-05 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $12 |
| 2025-10-21 | Raymond JamesChristopher Raymond |
Initiates coverage on | Strong buy | $13 |
| 2025-10-17 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $12 |
| 2025-10-17 | NeedhamGil Blum |
Reiterates | Buy | $10 |
| 2025-10-02 | BairdJack Allen |
Maintains | Outperform | $7 → $12 |
| 2025-10-02 | NeedhamGil Blum |
Maintains | Buy | $8 → $10 |
| 2025-08-13 | Wells FargoYanan Zhu |
Maintains | Overweight | $8 → $8 |
| 2025-08-13 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $11 → $14 |
| 2025-08-12 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $9 → $10 |
| 2025-07-11 | B of A SecuritiesTazeen Ahmad |
Initiates coverage on | Buy | $8 |
| 2025-07-01 | NeedhamGil Blum |
Reiterates | Buy | $8 |
| 2025-06-10 | NeedhamGil Blum |
Reiterates | Buy | $8 |
| 2025-06-03 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $9 → $11 |
| 2025-06-02 | NeedhamGil Blum |
Reiterates | Buy | $6 → $8 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.11
- Market Cap
- $1.28 billion
- 52-Week Range
- $2.71 – $7.30
- Average Volume
- 4.36 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.